Thursday 16 January 2020

McKesson Stock is doing well over the year

Pay close attention to the stock of McKesson (MCK). Over the last 12 months, the stock has grown well. The stock holds a P/E ratio of 9.86. Consider that its industry has an average P/E of 19.45. Another important valuation metric for MCK is its P/B ratio of 4.06. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. This stock's P/B looks strong versus its industry's average P/B of 4.43.

Of course, there are also other valuation metrics you can look at. McKesson gets a good value grade. The stock is somewhat likely to be undervalued right now.

McKesson Corporation is an interesting healthcare company. It is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The large company had revenues of $208.4 billion in 2018. McKesson is based in Irving, Texas. The massive company distributes health care systems, medical supplies and pharmaceutical products. To add to that, McKesson also provides extensive network infrastructure for the health care industry. Also, the company was an early adopter of technologies like bar-code scanning for distribution, pharmacy robotics, and RFID tags. It is a Fortune Global 500 company.

In 2014, McKesson acquired Celesio to become one of the world's largest health care companies, with over $179 billion in annual revenue.

Celesio AG is a German healthcare and pharmaceutical company, based in Stuttgart. The company operates in 14 countries around the world and generated revenue of more than 22,000 million euros in 2014. The corporation is part of the American McKesson Corporation who has a 76% stake in the company. The company website is

The stock of the company is: MCK (NYSE). The Headquarters of the company are in Irving, Texas, USA. The CEO is Brian S. Tyler (From Apr. 1, 2019).

Here are the McKesson Corporation Subsidiaries:

PSS World Medical
McKesson Canada
Rexall Drugstore
Health Mart
Celesio (76%)
McKesson Medical-Surgical Government Solutions LLC
Rexall Drugstore
Medical Specialties Distributors, LLC
MED3000, Inc.
McKesson UK Finance I Limited
McKesson Europe
Per-Se Technologies
McKesson Corporation
Laboratory Supply Company, Inc.
Cypress Medical Products LLC
Nadro S.A. de C.V.
McKesson International Holdings Ltd
CGSF Funding Corporation
McKesson Specialty Health
Norsk Medisinaldepot
PST Services, Inc.
Physician Sales & Service, Inc.
Mckesson High Volume Solutions Inc.
Onmark, Inc.
Macro Helix LLC
National Rehab Equipment, Inc.
Mckesson Global Procurement & Sourcing Limited
McKesson Specialty Arizona Inc.
Sivem Pharmaceuticals ULC
Mckesson Pharmacy Systems LLC
McKesson Specialty Care Distribution LLC
McKesson Medical Imaging Company
Sterling Medical Services, LLC
US Oncology Research, LLC
McKesson Plasma and Biologics LLC
Mckesson Provider Technologies, LLC
RMCC Cancer Center, LLC
Northstar Healthcare Limited
Health Mart Systems, Inc.
AccessMED, LLC
US Oncology Corporate, Inc.
Crocker Plaza Company
Unity Oncology, LLC
McKesson Nederland B.V.
McKesson Specialty Distribution LLC
AOR Management Company of Pennsylvania, LLC
ProPharm Limited
Keltman Pharmaceuticals, Inc.
McKesson Pharmacy Optimization LLC

No comments:

Post a Comment